Minerva Neurosciences | NERV - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Acadia Pharmaceuticals 11.33 1.25 2026-06
Adma Biologics 15.02 14.71 2026-03
ALKERMES 135.81 96.48 2026-06
AstraZeneca 25.34 4.25 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
Bristol-Myers Squibb 16.14 7.06 2026-06
Cipla 35.82 12.26 2026-06
Clal Biotechnology 11.67 2.62 2022-12
Compugen 5.45 1.39 2026-03
CSL 16.16 9.59 2025-12
Eli Lilly 32.9 7.37 2026-06
GlaxoSmithKline 10.63 4.24 2026-06
Grifols 11.2 1.08 2025-12
Halozyme Therapeutics 12.51 1.15 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
J&J 29.43 4.9 2026-06
Merck 32.26 15.74 2026-06
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
Novavax 2.01 1.07 2025-12
Pfizer 11.48 2.16 2026-06
Roche Holding 16.48 0.39 2026-06
Sanofi 18.96 7.12 2026-06
Takeda 24.4 22.12 2026-06
Vanda Pharmaceuticals 16.79 7.07 2023-06